A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dioxaphetyl butyrate
Gluconic Acid
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Gluconic Acid.
Dioxaphetyl butyrate
Plecanatide
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Plecanatide.
Dioxaphetyl butyrate
Lactitol
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Lactitol.
Dioxaphetyl butyrate
Sennosides
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sennosides.
Dioxaphetyl butyrate
Methylcellulose
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Methylcellulose.
Dioxaphetyl butyrate
Magnesium glycinate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium glycinate.
Dioxaphetyl butyrate
Castor oil
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Castor oil.
Dioxaphetyl butyrate
Magnesium citrate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium citrate.
Dioxaphetyl butyrate
Plantago seed
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Plantago seed.
Dioxaphetyl butyrate
Docusate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Docusate.
Dioxaphetyl butyrate
Carboxymethylcellulose
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Carboxymethylcellulose.
Dioxaphetyl butyrate
Mineral oil
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Mineral oil.
Dioxaphetyl butyrate
Sodium fluorophosphate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium fluorophosphate.
Dioxaphetyl butyrate
Potassium lactate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Potassium lactate.
Dioxaphetyl butyrate
Sodium sulfate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium sulfate.
Dioxaphetyl butyrate
Dipotassium phosphate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Dipotassium phosphate.
Dioxaphetyl butyrate
Monopotassium phosphate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Monopotassium phosphate.
Dioxaphetyl butyrate
Magnesium acetate tetrahydrate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium acetate tetrahydrate.
Dioxaphetyl butyrate
Polycarbophil
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Polycarbophil.
Dioxaphetyl butyrate
Magnesium trisilicate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium trisilicate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3